Ranbaxy generics entry

New Delhi, July 30: Ranbaxy Laboratories has commercialised its first authorised generic product, Isoptin SR — an anti-hypertensive agent — in the US market. Ranbaxy had reached an agreement with US-based FSC Laboratories, the patent holder of the original compound, Verapamil SR. “ Isoptin SR enhances our new drug delivery systems capability and our efforts with other molecules to improve patient compliance,” said K. Venkatachalam, vice-president and regional director (North America), Ranbaxy.

Telecom meet

New Delhi, July 30: The department of telecom has called a meeting of mobile operators to finalise on the spectrum allocation plans, which will include new services such as 3G and Wi-Max.

UTI Bank

Mumbai, July 30: UTI Bank has been officially named Axis Bank Ltd with effect from today. The registrar of companies has issued a fresh certificate of incorporation, the company informed the BSE.

Company law

New Delhi, July 30: The industry will have to wait a few more months for the revised Company Law, with the ministry of corporate affairs still working on the draft bill.

EU move

Brussels, July 30: The European Union has imposed tariffs on a chemical from India used in perfumes and soaps to help Spanish producers compete against cheaper imports.